Clinical Trials Logo

Dyslipidemia clinical trials

View clinical trials related to Dyslipidemia.

Filter by:

NCT ID: NCT00069004 Completed - HIV Infections Clinical Trials

A Study of Physical and Metabolic Abnormalities in HIV Infected and Uninfected Children and Youth

Start date: October 2003
Phase: N/A
Study type: Observational

The purpose of this study is to assess the prevalence of metabolic and physical abnormalities in HIV infected (via mother-to-child transmission) and uninfected children and youth. Metabolism, body composition, bone density, and other factors will be assessed in relationship to participants' exposure to highly active antiretroviral therapy (HAART).

NCT ID: NCT00029835 Completed - Obesity Clinical Trials

Obese Patients With Untreated Dyslipidemias

RIO-Lipids
Start date: September 2001
Phase: Phase 3
Study type: Interventional

To assess the effect on weight loss and weight maintenance over a period of one year when prescribed with a hypocaloric diet in obese patients with untreated dyslipidemia

NCT ID: NCT00017953 Completed - Stroke Clinical Trials

Look AHEAD: Action for Health in Diabetes

LookAHEAD
Start date: June 2001
Phase: N/A
Study type: Interventional

The Look AHEAD study is a multi-center, randomized clinical trial to examine the long-term effects of a lifestyle intervention designed to achieve and maintain weight loss. The study will investigate the effects of the intervention on heart attacks, stroke and cardiovascular-related death in individuals with type 2 diabetes who are also overweight or obese.

NCT ID: NCT00001154 Completed - Clinical trials for Hypercholesterolemia

Lipoprotein Metabolism in Normal Volunteers and Patients With High Levels of Lipoproteins

Start date: September 3, 1976
Phase:
Study type: Observational

Researchers plan to study the fat-rich particles, called lipoproteins, which circulate in the blood. This study is designed to improve understanding of normal, as well as abnormal, lipoprotein metabolism and the role it plays in the development of hardening of the arteries (atherosclerosis). Patients participating in this study will receive injections of lipoproteins or apolipoproteins (the protein component of lipoproteins) that have been isolated and purified. These lipoproteins will be labeled with small amounts of radioactive material and sterilized before they are injected into the patient. Patients participating in the study will be required to have blood samples taken, and provide urine samples throughout the course of the study. In addition, patient will be required to follow a specially formulated diet. Patients will be weighed throughout the course of the study.